Agilent receives FDA approval for PD-L1 IHC 28-8 pharmDx in ESCC and gastric cancers
The assay identifies PD-L1 expression in tumors, enabling treatment with nivolumab.
Stay informed with the latest news and media coverage for the biggest companies in Advanced Medical Equipment & Technology. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
The assay identifies PD-L1 expression in tumors, enabling treatment with nivolumab.
He is a seasoned MedTech executive with nearly three decades of experience and replaces Sang Yi.
The multi-year contract covers over 250,000 annual imaging exams and includes radiology and breast imaging modules.
The order reflects continued demand and follows a previous order from the distributor.
Unlock all announcements with a free trial
Agilent Technologies Inc. today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PD?L1 IHC 28?8 pharmDx assay as a...
Radiation therapy company Elekta falls nearly 9 percent on the Stockholm Stock Exchange after reports that China is expected to include large medical equipment in class A in a national...
UPPSALA, SE / ACCESS Newswire / July 14, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a company specializing in blood-based cancer monitoring, today announced that...
The Finnish medical technology company Nexstim has received a new order for ten NBS 6 systems from a distributor. Deliveries are planned for the second half of 2026.
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily news updates delivered straight to your inbox
Start for freeBrowse the top companies in Advanced Medical Equipment & Technology and stay on top of their latest developments.